{"id":"https://openalex.org/W53870033","doi":null,"title":"Dose-ranging efficacy of new once-daily extended-release minocycline for acne vulgaris.","display_name":"Dose-ranging efficacy of new once-daily extended-release minocycline for acne vulgaris.","publication_year":2006,"publication_date":"2006-10-01","ids":{"openalex":"https://openalex.org/W53870033","mag":"53870033","pmid":"https://pubmed.ncbi.nlm.nih.gov/17436825"},"language":"en","primary_location":{"id":"pmid:17436825","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17436825","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cutis","raw_type":"Clinical Trial, Phase II"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103012800","display_name":"Daniel M Stewart","orcid":"https://orcid.org/0000-0002-4087-5544","observed_orcids":["https://orcid.org/0000-0002-4087-5544"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel M Stewart","raw_affiliation_strings":["Midwest Cutaneous Research Corporation, Clinton Township, Michigan, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Midwest Cutaneous Research Corporation, Clinton Township, Michigan, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Helen Mary Torok","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Helen Mary Torok","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103527846","display_name":"Jonathan Weiss","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jonathan S Weiss","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000915267","display_name":"R Todd Plott","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Todd Plott","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.7162,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.82341927,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"78","issue":"4 Suppl","first_page":"11","last_page":"20"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/minocycline","display_name":"minocycline","score":0.7310000061988831},{"id":"https://openalex.org/keywords/extended-release-formulation","display_name":"sustained-release formulation","score":0.9259999990463257},{"id":"https://openalex.org/keywords/acne-vulgaris","display_name":"acne","score":0.9869999885559082},{"id":"https://openalex.org/keywords/dose-ranging-study","display_name":"dose-ranging","score":0.8790000081062317},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.9369999766349792},{"id":"https://openalex.org/keywords/inflammatory-lesions","display_name":"inflammatory lesions","score":0.7310000061988831},{"id":"https://openalex.org/keywords/central-nervous-system-adverse-effects","display_name":"central nervous system adverse effects","score":0.9309999942779541},{"id":"https://openalex.org/keywords/tetracycline-antibiotics","display_name":"tetracycline antibiotics","score":0.6669999957084656},{"id":"https://openalex.org/keywords/facial-acne","display_name":"facial acne","score":0.6970000267028809}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9474241733551025},{"id":"https://openalex.org/C2778275353","wikidata":"https://www.wikidata.org/wiki/Q415336","display_name":"Minocycline","level":3,"score":0.8298370242118835},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.8154141306877136},{"id":"https://openalex.org/C2776312127","wikidata":"https://www.wikidata.org/wiki/Q5299247","display_name":"Dose-ranging study","level":5,"score":0.7620127201080322},{"id":"https://openalex.org/C2777673923","wikidata":"https://www.wikidata.org/wiki/Q79928","display_name":"Acne","level":2,"score":0.7513617277145386},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6854598522186279},{"id":"https://openalex.org/C162156334","wikidata":"https://www.wikidata.org/wiki/Q473420","display_name":"Dose","level":2,"score":0.6783822774887085},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6431756019592285},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.41301029920578003},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38083407282829285},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3327851891517639},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.2858543395996094},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.16160428524017334},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.12520527839660645},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000152","descriptor_name":"Acne Vulgaris","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008911","descriptor_name":"Minocycline","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008911","descriptor_name":"Minocycline","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015992","descriptor_name":"Body Mass Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:17436825","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17436825","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cutis","raw_type":"Clinical Trial, Phase II"},{"id":"mag:53870033","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17436825","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2301570629","https://openalex.org/W271001793","https://openalex.org/W2416667298","https://openalex.org/W3117478263","https://openalex.org/W1983218059","https://openalex.org/W2947009697","https://openalex.org/W2135706410","https://openalex.org/W2236209428","https://openalex.org/W94565345","https://openalex.org/W2158956076"],"abstract_inverted_index":{"A":[0,184],"multicenter,":[1],"12-week,":[2],"randomized,":[3],"double-blinded,":[4],"placebo-controlled,":[5],"dose-ranging":[6],"study":[7],"was":[8,90,133],"conducted":[9],"in":[10,83,96,102,126,130,154,163],"233":[11],"subjects":[12],"with":[13,36,48,92,149,172,198,204],"moderate":[14],"to":[15,20,46,109,145],"severe":[16],"facial":[17],"acne":[18],"vulgaris":[19],"determine":[21],"the":[22,37,66,69,72,84,93,97,103,119,127,150,155,164,189,194,199],"lowest":[23,156,195],"effective":[24,196],"once-daily":[25],"oral":[26],"dose":[27,85,147,197],"of":[28,51,68,74,99,176,188],"a":[29,173],"new":[30,190],"extended-release":[31],"(ER)":[32],"minocycline":[33],"hydrochloride":[34],"formulation":[35,192],"safest":[38,200],"adverse":[39,141],"effect":[40,89,202],"profile.":[41],"Subjects":[42],"randomly":[43],"were":[44,170],"assigned":[45],"treatment":[47,105],"daily":[49,59,186],"dosages":[50],"ER-minocycline":[52,120,191],"1-,":[53],"2-,":[54],"or":[55,58,110],"3-mg/kg":[56],"tablets,":[57,61],"placebo":[60,124,165],"for":[62],"84":[63],"days.":[64],"At":[65],"end":[67],"12":[70],"weeks,":[71],"number":[73,98],"inflammatory":[75,100,131],"lesions":[76,101,132],"decreased":[77],"approximately":[78],"50%":[79],"from":[80],"baseline":[81],"levels":[82],"groups.":[86],"No":[87],"dose-dependent":[88],"observed,":[91],"percentage":[94,128],"decrease":[95,129],"1-mg/kg":[104,185],"group":[106,160,166],"being":[107,152],"equal":[108],"greater":[111],"than":[112],"higher":[113,174],"doses.":[114],"The":[115],"pairwise":[116],"difference":[117],"between":[118],"1":[121],"mg/kg":[122],"and":[123,162,182],"groups":[125],"statistically":[134],"significant":[135],"(P":[136],"=":[137],".015).":[138],"Acute":[139],"vestibular":[140],"events":[142],"(AVAEs)":[143],"appeared":[144],"be":[146],"proportional,":[148],"incidence":[151,175],"similar":[153],"(1":[157],"mg/kg)":[158],"dosing":[159],"(24%)":[161],"(26%).":[167],"Higher-dose":[168],"regimens":[169,206],"associated":[171],"central":[177],"nervous":[178],"system":[179],"side":[180,201],"effects":[181],"AVAEs.":[183],"dosage":[187],"is":[193],"profile,":[203],"higher-dose":[205],"offering":[207],"no":[208],"substantial":[209],"therapeutic":[210],"advantages.":[211]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}